superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2018-04-01
- Valid until
- 2018-07-01
- Published
- 2019-05-09
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 13,466,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Pfizer quarterly revenue: 12,906,000,000 United States dollar", as of 2018-04-01 (until 2018-07-01). Claim clm_93302DB1670E, https://asof.is/claim/clm_93302DB1670E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/78003/000007800319000026/0000078003-19-000026-index.htm.
APA
AsOf. (2018). Pfizer quarterly revenue: 12,906,000,000 United States dollar (as of 2018-04-01 (until 2018-07-01)) [Record clm_93302DB1670E]. Retrieved November 10, 2026, from https://asof.is/claim/clm_93302DB1670E (source: https://www.sec.gov/Archives/edgar/data/78003/000007800319000026/0000078003-19-000026-index.htm)
BibTeX
@misc{asof_clm_93302DB1670E,
author = {AsOf},
title = {Pfizer quarterly revenue: 12,906,000,000 United States dollar},
year = {2018},
howpublished = {\url{https://asof.is/claim/clm_93302DB1670E}},
note = {Claim clm\_93302DB1670E, as of 2018-04-01 (until 2018-07-01); source: https://www.sec.gov/Archives/edgar/data/78003/000007800319000026/0000078003-19-000026-index.htm},
urldate = {2026-11-10}
}Supersedes
On the record
/claim/clm_93302DB1670E.md/v1/claims/clm_93302DB1670Esubmit a correction